Peer-influenced content. Sources you trust. No registration required. This is HCN.
Neurology Advisor
Explore the potential of tDCS as a non-pharmacological intervention for Alzheimer’s disease, demonstrating significant cognitive improvements linked to enhanced cortical plasticity, without serious adverse effects.
Neurology March 5th 2024
Practical Neurology
The TASTE-SL trial presents compelling evidence that Sanbexin, a sublingual combination of edaravone and dexborneol, offers a significant improvement in recovery for acute ischemic stroke patients, marking a notable advancement in neuroprotective treatment strategies.
In the evolving landscape of MS treatment, the strategic choice between early aggressive and escalation therapies is critical. Understanding the nuances of patient-specific factors, such as age and disease activity, can significantly influence outcomes and guide effective management.
SingleCare
Explore the integration of service animals into patient care plans, highlighting their role in enhancing independence and supporting diverse medical needs.
Medical News Today (MNT)
Explore the intersection of dietary intervention and biological aging: a fasting-mimicking diet presents a promising avenue for reducing age-related biomarkers and improving metabolic health, offering new strategies in disease prevention and patient care.
Endocrinology, Diabetes, Metabolism March 5th 2024
MDLinx
Physicians should be aware of the phenomenon of “eclipse sickness,” where patients report a variety of symptoms during and after solar eclipses. Understanding the psychological and social factors at play can aid in addressing patient concerns effectively, despite the lack of empirical evidence linking eclipses to physical health outcomes.
Emergency Medicine March 5th 2024